Active
miDiagnostics logo

miDiagnostics

Switched

BE0641984602

Rechtspersoon Public limited company 2 establishments

Gaston Geenslaan 1, 3001 Leuven Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies midiagnostics.com

Active for

10 year, 10 months

Financials

Financial year 2025

Worth noting

  • More debts than assets in the latest financial year.
  • A loss two years in a row.
  • The team shrank two years in a row.
  • Little cash and receivables against the short-term debts.

Revenue

€ 24,934

▲ 72% vs 2024

Profit

Caution

€ -12.6 million

▲ 32% vs 2024

Debts

High

€ 22.2 million

▼ 12% vs 2024

miDiagnostics from Leuven, company number BE0641984602, closed financial year 2025 with a result of € -12.6 million after tax. For that financial year miDiagnostics recorded revenue of € 24,934 and equity of € -10.6 million. Compared with financial year 2024, the result moved from € -18.6 million to € -12.6 million. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 24, 2026.

What happened at miDiagnostics?

What happened at miDiagnostics in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Pamica NV stepped down as director. NBB
  • Van den Bruinhorst Management Consultancy BV stepped down as director. NBB
  • BEVER Consulting BV stepped down as director. NBB
  • Peter Verhaeghe stepped down as director. NBB
  • DR. IR. U. Vandeurzen Management Firm NV stepped down as director. NBB
  • New annual accounts for financial year 2025: loss of € 12.6 million. Source: NBB ↗
  • Pamica NV became a director. NBB
  • Van den Bruinhorst Management Consultancy BV became a director. NBB

In short

From € 17.7 million loss in 2021 to € 12.6 million loss in 2025.

Pays suppliers within 66 days on average.

A new publication or filing at miDiagnostics? We notify you, reason included.

Follow miDiagnostics

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Alychlo NV 31.8%
VF Capital 22.4%
Pamica NV 12.4%
+6
miDiagnostics

The shares are held by Alychlo NV (31.8%), VF Capital (22.4%), Pamica NV (12.4%), Fidimec NV (6.9%), Thermo Fisher Diagnostics (6.5%) and Participatiemaatschappij Vlaanderen (6.4%).

See the full network in the app

Directors

According to the 2025 annual accounts

Pamica NV

Director · represented by Akkermans Michel Gustaaf

Also active at: Interuniversitair Micro-Electronica Centrum, APPROACH BELGIUM, IntellectEU +9 more

since 2024 · until 2030

Van den Bruinhorst Management Consultancy BV

Director · represented by Willem Van Den Bruinhorst

since 2024 · until 2030

BEVER Consulting BV

Director · represented by Els Degroote

Also active at: Smartphoto group, WEDIM, ENSO HOSPITALITY +15 more

since 2024 · until 2030

since 2024 · until 2030

DR. IR. U. Vandeurzen Management Firm NV

Director · represented by Urbanus Vandeurzen

Owns 22.4% via VF Capital

Also active at: DI LEGNO INTERIORS, DLI Invest, Fund+ +10 more

since 2024 · until 2030

Shareholders

VF Capital · holding of DR. IR. U. Vandeurzen Management Firm NV

22.4%

Pamica NV

12.4%

Thermo Fisher Diagnostics

6.5%

Johns Hopkins University

1.4%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Gaston Geenslaan 1

3001 Leuven

2.331.872.872

Vaartdijk 59 box 2

3018 Leuven

Active since 1 March 2022

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

Technologies

Contact Form 7Cookie ConsentCookieYesFont AwesomeGoogle AnalyticsGoogle FontsGravity FormsNginxPHPSlickWPBakeryWooCommerceWordPressYoast SEOjQuery

Hosting & Email

Email provider

Microsoft 365

Hosting

GODADDY-SXB, DE

Domain

Domain

midiagnostics.com

Registered

2014-07-17

Registrar

Combell NV

Expires

2026-07-17

Website info

HTTPS Ja
Languages EN

Features

Webshop Blog Contact page

Security

HTTPS
SPF
DMARC

Details

Company number
0641.984.602
VAT number
BE 0641.984.602
Registered office
Gaston Geenslaan 1, 3001 Leuven
Names & denominations
miDiagnostics
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
28 October 2015
Peppol
Active · Active since 21 Oct 2025
Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Frequently asked questions

What is the enterprise number of miDiagnostics?
The enterprise number of miDiagnostics is BE0641984602.
What is the address of miDiagnostics?
The registered office of miDiagnostics is located at Gaston Geenslaan 1, 3001 Leuven.
When was miDiagnostics founded?
miDiagnostics was founded on 28 October 2015.
What is the main activity of miDiagnostics?
The main activity of miDiagnostics is "Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies" (NACE code 70200).
Does miDiagnostics have a website?
Yes, miDiagnostics has a website at midiagnostics.com.
Does miDiagnostics have an online shop?
Yes, miDiagnostics has an online shop.
Is miDiagnostics active on social media?
No social media profiles are currently known for miDiagnostics.
How much profit did miDiagnostics make in 2025?
miDiagnostics recorded a loss after taxes of € 12,595,117 in financial year 2025.
What is the revenue of miDiagnostics?
In its most recent annual accounts (2025), miDiagnostics reported revenue of € 24,934.
How many employees does miDiagnostics have?
According to the 2025 annual accounts, miDiagnostics has 54.2 full-time equivalents (FTE).
Where can I find the annual accounts of miDiagnostics?
miDiagnostics files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of miDiagnostics?
According to the 2025 annual accounts, the directors of miDiagnostics are: Pamica NV, Van den Bruinhorst Management Consultancy BV, BEVER Consulting BV, Peter Verhaeghe, DR. IR. U. Vandeurzen Management Firm NV.
Who owns miDiagnostics?
The shares are held by Alychlo NV (31.8%), VF Capital (22.4%), Pamica NV (12.4%), Fidimec NV (6.9%), Thermo Fisher Diagnostics (6.5%) and Participatiemaatschappij Vlaanderen (6.4%).
Who are the shareholders of miDiagnostics?
According to the 2025 annual accounts, the shareholders of miDiagnostics are: Alychlo NV (31.8%), VF Capital (22.4%), Pamica NV (12.4%), Fidimec NV (6.9%), Thermo Fisher Diagnostics (6.5%), Participatiemaatschappij Vlaanderen (6.4%), Smile Invest NV (6.1%), Praesens Foundation (Praesens DX) (5%), Johns Hopkins University (1.4%), Post Verba Verbera NV (1.3%).